Define: Safety Issue
In a contract, a Safety Issue is a defined trigger, typically found in pharmaceutical, clinical trial, or supply agreements, referring to any new information, adverse event, or emerging concern that could alter the risk-benefit balance of a drug or product. Its occurrence usually obligates parties to notify each other, investigate, and potentially suspend distribution or use.
Legal accuracy standard set & glossary spot-checked by Imad Mohammed Nazar , Skadden-trained M&A lawyer, Legal Engineer at GenieAI
What Safety Issue Means in a Contract
A Safety Issue clause identifies the circumstances under which a party must treat newly discovered information about a product, drug, or service as significant enough to reassess whether the benefits still outweigh the risks. This is not a vague reference to general product safety; it is a defined contractual trigger that activates specific obligations, such as notification, escalation, or suspension of activity, once a qualifying event occurs.
The concept is most common in life sciences and healthcare contracts, including clinical trial agreements, licensing deals, and supply arrangements, where one party manufactures or distributes a product developed or approved by another. Because the consequences of ignoring a genuine safety concern can include regulatory sanctions, injury claims, or reputational damage, contracts often build a Safety Issue definition into their risk allocation and compliance framework from the outset.
How Safety Issue Is Defined or Measured
Most definitions of Safety Issue hinge on two elements: an event or piece of information, and a demonstrable or potential effect on the risk-benefit balance of the product. The trigger might be an unexpected adverse event reported by a patient, a pattern identified through post-market surveillance, a regulatory inquiry, or new scientific data suggesting a previously unknown side effect.
Contracts vary in how strict or broad this threshold is. Some require the issue to be.
Relevant Circumstances
- Introduction of a new drug or product
- Change in production or formulation of a drug
- Incidents resulting in an adverse event during product usage
- Feedback or data suggesting a potential safety risk